Rock Springs Capital Management LP Deciphera Pharmaceuticals, Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $9.19 Million - $12.2 Million	-209,829 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $4.64 Million - $8.14 Million	-125,171 Reduced 37.36%	209,829 $12.5 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $2.92 Million - $6.03 Million	-86,890 Reduced 20.6%	335,000 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $5.45 Million - $12 Million	171,890 Added 68.76%	421,890 $26.3 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $4.99 Million - $9.71 Million	250,000 New	250,000 $8.49 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.